Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Understanding health technology assessment.

¹The Lewin Group, Quintile Scotland Limited, Heriot-Watt University Research Park, Edinburgh, UK. amcraig@quintiles.com

Medical Device Technology

|August 26, 2004

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The Canadian National EMS Research Agenda: Impact and Feasibility of Implementation of Previously Generated Recommendations.

CJEM·2015

Same author

Validation of a novel extraction method for studying hexahydro-1,3,5-trinitro-1,3,5 triazine (RDX) biodegradation by ruminal microbiota.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2013

Same author

Anaerobic transformation of octahydro-1,3,5,7-tetranitro-1,3,5,7-tetrazocine (HMX) by ovine rumen microorganisms.

Research in microbiology·2012

Same author

Flaxseed supplementation decreases methanogenic gene abundance in the rumen of dairy cows.

Animal : an international journal of animal bioscience·2012

Same author

Anaerobic bioremediation of RDX by ovine whole rumen fluid and pure culture isolates.

Applied microbiology and biotechnology·2012

Same author

Ovine ruminal microbes are capable of biotransforming hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX).

Microbial ecology·2011

Same journal

Safer arterial access.

Medical device technology·2010

Same journal

Building better surfaces.

Medical device technology·2010

Same journal

PVC: a broader perspective.

Medical device technology·2010

Same journal

Joining and forming using torsional ultrasonic principles.

Medical device technology·2010

Same journal

US regulation of combination products.

Medical device technology·2010

Same journal

Assessing biological safety of metals associated with medical devices.

Medical device technology·2010

See all related articles

Medical device manufacturers must demonstrate both cost and clinical effectiveness for new technologies to ensure efficient healthcare resource allocation. This involves a comprehensive assessment process to prove value for money.

Area of Science:

Health economics
Medical technology assessment
Healthcare policy

Background:

National healthcare resources are limited, necessitating careful allocation.
The adoption of new medical technologies depends on proven cost and clinical effectiveness.
Medical device manufacturers face increasing pressure to justify their products' value.

Purpose of the Study:

To outline the methodology for assessing the value for money of new medical technologies.
To guide medical device manufacturers in demonstrating the economic and clinical benefits of their innovations.

Main Methods:

The article details a systematic process for conducting value-for-money assessments.
This includes evaluating both clinical efficacy and economic impact.

Related Experiment Videos

Main Results:

A structured approach is essential for demonstrating value.
Evidence of cost-effectiveness alongside clinical effectiveness is crucial for market adoption.

Conclusions:

Medical device manufacturers must prioritize value-for-money assessments.
Successful technology diffusion relies on robust evidence of economic and clinical benefits.